Flutiform

Flutiform Indications/Uses

fluticasone + formoterol

Manufacturer:

Mundipharma

Distributor:

DKSH

Marketer:

Meiji
Full Prescribing Info
Indications/Uses
Flutiform inhaler is indicated in the regular treatment of asthma in patients 12 years of age and older, where the use of a combination product (an inhaled corticosteroid and a long-acting beta2 agonist) is appropriate.
For patients not adequately controlled with inhaled corticosteroids and 'as required' inhaled short-acting beta2 agonist, or for patients already adequately controlled on both and inhaled corticosteroid and a long-acting beta2 agonist.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in